+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hematologic effects of recombinant human granulocyte macrophage colony stimulating factor and interleukin-6 administered to patients with malignancy



Hematologic effects of recombinant human granulocyte macrophage colony stimulating factor and interleukin-6 administered to patients with malignancy



Blood 84(10 Suppl. 1): 598A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031662807

Download citation: RISBibTeXText


Related references

Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74(8): 2644-2651, 1989

The effects of recombinant human granulocyte macrophage colony stimulating factor gm csf granulocyte colony stimulating factor g csf and interleukin 3 il 3 on human neutrophil pmn oxidative activity and migration. Clinical Research 38(2): 458A, 1990

Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha tumor necrosis factor alpha granulocyte colony stimulating factor and murine recombinant granulocyte macrophage colony stimulating factor. Journal of Immunology 140(1): 108-111, 1988

Effects of bacterially synthesized recombinant human granulocyte macrophage colony stimulating factor in patients with advanced malignancy. Annals of Internal Medicine 110(5): 357-364, 1989

Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil. Journal of the National Cancer Institute 82(12): 1031-1037, 1990

Hematologic Effects of Interleukin-1 , Granulocyte Colony-Stimulating Factor, and Granulocyte-Macrophage Colony-Stimulating Factor in Tumor-bearing Mice Treated With Fluorouracil. Jnci Journal of the National Cancer Institute 82(12): 1031-1037, 1990

The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 81(7): 1863-1870, 1993

Therapeutic efficacy of the combined administration of either recombinant human interleukin-6 and rh Granulocyte colony stimulating factor or rh Granulocyte-macrophage colony stimulating factor in a primate model of radiation-induced marrow aplasia. Experimental Hematology 22(8): 684, 1994

Recombinant human interleukin 3 and recombinant human granulocyte macrophage colony stimulating factor administered in vivo after high dose cyclophosphamide cancer chemotherapy effect on hematopoiesis and microenvironment in human bone marrow. Blood 79(10): 2610-2619, 1992

The effects in vivo of purified preparations of murine macrophage colony stimulating factor-1, recombinant murine granulocyte-macrophage colony stimulating factor and natural and recombinant murine interleukin 3 without and with pretreatment of mice with purified iron-saturated human lactoferrin. Immunobiology 172(3-5): 168-174, 1986

Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures. International Journal of Cell Cloning 7(1): 39-49, 1989

The proliferative effects of human granulocyte macrophage colony stimulating factor alpha and granulocyte macrophage colony stimulating factor beta and murine granulocyte colony stimulating factor in microwell cultures of fractionated human marrow cells. Leukemia Research 9(5): 521-528, 1985

Phase i ii study of recombinant human granulocyte macrophage colony stimulating factor in patients with advanced malignancy. Acta Haematologica 87(1-2): 22-28, 1992

Phase l/ll Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Advanced Malignancy. Acta Haematologica 87(1-2): 22-28, 1992

Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Bulletin du Cancer (Paris) 80(5): 418-430, 1993